Other Clinical Trial - Compassionate Use of Omegaven IV Fat Emulsion

Status Withdrawn

Clinical Trial Summary

The purpose of the study is to provide use of Omegaven in children with life threatening Total Parenteral Nutrition (TPN) associated cholestasis when all other medical and surgical treatments/therapies have been either ineffective or not feasible in the treatment of this serious condition. This is a compassionate use protocol.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Cholestasis
Total Parenteral Nutrition-induced Cholestasis

Clinical Trial Details

NCT number	NCT01323907
Study type	Interventional
Source	Columbia University
Contact
Status	Withdrawn
Phase	N/A
Start date	January 2011
Completion date	February 13, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02370251` - Compassionate Use of Omegaven in Children	Phase 2/Phase 3
Completed	`NCT01845116` - Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury	Phase 2
Recruiting	`NCT01565278` - Fish Oil for Patients With Liver Disease Due to Parenteral Nutrition	Phase 3
Terminated	`NCT00816348` - Compassionate Use of Omegaven IV Fat Emulsion	Phase 2
Completed	`NCT02534077` - Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Infants	Phase 3
Approved for marketing	`NCT01412359` - Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Associated Hepatic Injury
Approved for marketing	`NCT02328768` - Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children
Approved for marketing	`NCT02780193` - Intravenous Fish Oils in the Treatment of Parenteral Nutrition Liver Injury
Approved for marketing	`NCT02929303` - Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD